Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma

Volume: 10, Issue: 3, Pages: 401 - 412
Published: Apr 15, 2020
Abstract
Hedgehog inhibitors are promising alternative treatments for patients with advanced basal cell carcinomas. Sonidegib (Odomzo®), an oral smoothened (SMO) antagonist, is indicated for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) who present recurrence following surgery or radiation therapy, or those who are not candidates for surgery or radiotherapy. Several studies and randomized controlled trials have been...
Paper Details
Title
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
Published Date
Apr 15, 2020
Volume
10
Issue
3
Pages
401 - 412
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.